About
AI Drug Discovery
Areas of Focus
Categories
AI FocusedNJ, NY, PA
Team (7)
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
223
By Phase
PHASE1: 6
By Status
TERMINATED: 4RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05780034Lead Sponsor
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
PHASE1Recruiting
60 participants
Started: Jun 20, 2023 · Completed: May 31, 2026
NCT05673109Lead Sponsor
A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer
PHASE1Terminated
8 participants
Started: Feb 22, 2023 · Completed: Oct 8, 2023
NCT05654532Lead Sponsor
Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer
PHASE1Active, not recruiting
100 participants
Started: Dec 29, 2022 · Completed: May 31, 2026
NCT05489679Lead Sponsor
A Study of AC682 In Chinese Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer
PHASE1Terminated
6 participants
Started: Oct 1, 2022 · Completed: Sep 28, 2023
NCT05241613Lead Sponsor
A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer
PHASE1Terminated
28 participants
Started: Mar 16, 2022 · Completed: Mar 5, 2024
Locations (1)
Headquarters
Cranbury, NJ, United States
Map
Loading map...